Hanall Biopharma Co.,Ltd (009420.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 49,000.00

From 52W high−31.90%

Volume246134.00

Market capKRW 2.52T

P/E (TTM)—

P/S (TTM)15.5x

Div yield—

Key dataSep 18, 2026

Open

KRW 49,000.00

From 52W high

−31.90%

Volume

246134.00

Market cap

KRW 2.52T

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−186.9x

P/E (TTM)

—

RSI (14)

35.8

MomentumView details →

1D Return

+0.84%

YTD Return

+8.91%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−186.9x

EV/Sales

15.6x

P/S (TTM)

15.5x

P/B (TTM)

15.6x

ProfitabilityView details →

Gross Margin

52.08%

Net Margin

−15.31%

EBITDA Margin

−8.32%

ROE (TTM)

−15.41%

ROA (TTM)

−10.35%

Asset Turnover

0.67x

GrowthView details →

Revenue YoY

+8.38%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+12.16%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+0.84%

YTD Return

+8.91%

1Y Return

+45.50%

RSI (14)

35.8

vs 50D SMA

−10.80%

vs 200D SMA

−8.74%

Capital & dividendView details →

Debt/Equity

0.28x

Current Ratio

1.49x

Quick Ratio

0.84x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−KRW 368.09

EPS Surprise

−812.52%

Beats (12Q)

0/12

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

−812.52%

Rev Surprise

12.95%

Financials snapshotView financials →

Revenue (TTM)

162.66B

Net Income (TTM)

−24.90B

Op. CF (TTM)

−1.24B

Latest newsMore news →

No recent news for 009420.KS.

Similar companies

Celltrion Pharm, Inc.068760.KQ Daewoong pharmaceutical Co.,Ltd069620.KS JW Pharmaceutical Corporation001067.KS Yuhan Corporation000105.KS Yuhan Corporation000100.KS DongKook Pharmaceutical Co., Ltd.086450.KQ Find similar companies →

Latest newsMore news →

No recent news for 009420.KS.